Clinical Trial Update: Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 trial reports observation on immune persistence after vaccination with five doses of a rabies vaccine in people aged 10–60 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Rabies vaccine (rabies vaccine)

Snippet

Sponsor: Changchun Zhuoyi Biological Co., Ltd | Conditions: Rabies, Antibody | Phase 4 | Status: COMPLETED